Showing results (21-30 of 23) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Dermatological Treatment|May 1, 2020
Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trialsK B Gordon, K Reich, J J Crowley, et al.The British Journal of Dermatology|February 5, 2021
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)D Thaci, S Piaserico, R B Warren, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2022
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2A P Fernandez, E Dauden, S Gerdes, et al.Pageof 3